Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mongan

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Frontiers in Veterinary Science|August 20, 2021
Immunohistochemical Characterisation of GLUT1, MMP3 and NRF2 in OsteosarcomaCatrin S Rutland, James M Cockcroft, Jennifer Lothion-Roy, et al.
Frontiers in Immunology|May 30, 2023
Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancersShahd Talhouni, Wakkas Fadhil, Nigel P Mongan, et al.
British Journal of Cancer|September 28, 2019
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancerChitra Joseph, Sara Al-Izzi, Mansour Alsaleem, et al.
Scientific Reports|February 18, 2022
Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancerSasagu Kurozumi, Kyoichi Kaira, Hiroshi Matsumoto, et al.
Cancers|August 29, 2020
Molecular Characterisation of Canine Osteosarcoma in High Risk BreedsSiobhan Simpson, Mark Dunning, Simone de Brot, et al.
Breast Cancer Research and Treatment|December 17, 2018
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancerChitra Joseph, Maariya Arshad, Sasagu Kurozomi, et al.
Breast Cancer Research : BCR|August 13, 2020
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasetsSasagu Kurozumi, Mansour Alsaleem, Cíntia J Monteiro, et al.
Journal of Medical Cases|August 26, 2021
Vaginal Myomectomy and Total Vaginal Hysterectomy on Large Prolapsed Cervical Myoma: A Case ReportFrank M M Wagey, Rudy Lengkong, Freddy W Wagey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2023
Deciphering the Morphology of Tumor-Stromal Features in Invasive Breast Cancer Using Artificial IntelligenceNehal M Atallah, Noorul Wahab, Michael S Toss, et al.
British Journal of Cancer|September 30, 2023
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligenceShorouk Makhlouf, Noorul Wahab, Michael Toss, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Frontiers in Veterinary Science|August 20, 2021
Immunohistochemical Characterisation of GLUT1, MMP3 and NRF2 in OsteosarcomaCatrin S Rutland, James M Cockcroft, Jennifer Lothion-Roy, et al.
Frontiers in Immunology|May 30, 2023
Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancersShahd Talhouni, Wakkas Fadhil, Nigel P Mongan, et al.
British Journal of Cancer|September 28, 2019
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancerChitra Joseph, Sara Al-Izzi, Mansour Alsaleem, et al.
Scientific Reports|February 18, 2022
Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancerSasagu Kurozumi, Kyoichi Kaira, Hiroshi Matsumoto, et al.
Cancers|August 29, 2020
Molecular Characterisation of Canine Osteosarcoma in High Risk BreedsSiobhan Simpson, Mark Dunning, Simone de Brot, et al.
Breast Cancer Research and Treatment|December 17, 2018
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancerChitra Joseph, Maariya Arshad, Sasagu Kurozomi, et al.
Breast Cancer Research : BCR|August 13, 2020
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasetsSasagu Kurozumi, Mansour Alsaleem, Cíntia J Monteiro, et al.
Journal of Medical Cases|August 26, 2021
Vaginal Myomectomy and Total Vaginal Hysterectomy on Large Prolapsed Cervical Myoma: A Case ReportFrank M M Wagey, Rudy Lengkong, Freddy W Wagey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2023
Deciphering the Morphology of Tumor-Stromal Features in Invasive Breast Cancer Using Artificial IntelligenceNehal M Atallah, Noorul Wahab, Michael S Toss, et al.
British Journal of Cancer|September 30, 2023
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligenceShorouk Makhlouf, Noorul Wahab, Michael Toss, et al.
Pageof 20